A PHASE-II STUDY OF IDARUBICIN AND PREDNISONE IN MULTIPLE-MYELOMA

被引：8

作者：

ALBERTS, AS ^{[1
]}

FALKSON, G ^{[1
]}

RAPOPORT, BL ^{[1
]}

UYS, A ^{[1
]}

机构：

[1] UNIV PRETORIA,DEPT MED ONCOL,POB 667,PRETORIA 0001,SOUTH AFRICA

来源：

TUMORI | 1990年 / 76卷 / 05期

关键词：

D O I：

10.1177/030089169007600509

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：465 / 466

页数：2

共 7 条

[1]

BERGSAGEL DE, 1985, CANC PRINCIPLES PRAC, P1753

[2] A PHASE-II STUDY OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED MYELOMA [J].

CHISESI, T ;

CAPNIST, G ;

DEDOMINICIS, E ;

DINI, E .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04) :681-684

[3]

DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO

[4]

2-U

[5] THERAPEUTIC ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN ADULT ACUTE-LEUKEMIA [J].

LAMBERTENGHIDELILIERS, G ;

POGLIANI, E ;

MAIOLO, AT ;

PACCIARINI, MA ;

POLLI, EE .

TUMORI JOURNAL, 1983, 69 (06) :515-519

[6]

LOPEZ M, 1985, 14TH INT C CHEM KYAT, V39

[7] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

← 1 →